Cargando…

COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study

BACKGROUND: Our objective was to assess the effects of COVID‐19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. SUBJECTS, MATERIALS, AND METHODS: We performed a retrospective, populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrdoljak, Eduard, Balja, Melita Perić, Marušić, Zlatko, Avirović, Manuela, Blažičević, Valerija, Tomasović, Čedna, Čerina, Dora, Bajić, Žarko, Miše, Branka Petrić, Lovasić, Ingrid Belac, Flam, Josipa, Tomić, Snježana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250475/
https://www.ncbi.nlm.nih.gov/pubmed/33856084
http://dx.doi.org/10.1002/onco.13791
_version_ 1783717053957406720
author Vrdoljak, Eduard
Balja, Melita Perić
Marušić, Zlatko
Avirović, Manuela
Blažičević, Valerija
Tomasović, Čedna
Čerina, Dora
Bajić, Žarko
Miše, Branka Petrić
Lovasić, Ingrid Belac
Flam, Josipa
Tomić, Snježana
author_facet Vrdoljak, Eduard
Balja, Melita Perić
Marušić, Zlatko
Avirović, Manuela
Blažičević, Valerija
Tomasović, Čedna
Čerina, Dora
Bajić, Žarko
Miše, Branka Petrić
Lovasić, Ingrid Belac
Flam, Josipa
Tomić, Snježana
author_sort Vrdoljak, Eduard
collection PubMed
description BACKGROUND: Our objective was to assess the effects of COVID‐19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. SUBJECTS, MATERIALS, AND METHODS: We performed a retrospective, population‐ and registry‐based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly diagnosed breast cancer cases. RESULTS: The average monthly percent change after the initial lockdown measures were introduced was −11.0% (95% confidence interval − 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017–2019. CONCLUSION: It seems that national health care system measures for controlling the spread of COVID‐19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID‐19 control measures were relaxed, and it has not reoccurred during the second COVID‐19 wave. Although the COVID‐19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020. IMPLICATIONS FOR PRACTICE: It is possible to compensate for the adverse effects of COVID‐19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non‐negligible extent.
format Online
Article
Text
id pubmed-8250475
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-82504752021-07-02 COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study Vrdoljak, Eduard Balja, Melita Perić Marušić, Zlatko Avirović, Manuela Blažičević, Valerija Tomasović, Čedna Čerina, Dora Bajić, Žarko Miše, Branka Petrić Lovasić, Ingrid Belac Flam, Josipa Tomić, Snježana Oncologist European Perspectives BACKGROUND: Our objective was to assess the effects of COVID‐19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers in the Republic of Croatia. SUBJECTS, MATERIALS, AND METHODS: We performed a retrospective, population‐ and registry‐based study during 2020. The comparator was the number of patients newly diagnosed with breast cancer during 2017, 2018, and 2019. The outcome was the change in number of newly diagnosed breast cancer cases. RESULTS: The average monthly percent change after the initial lockdown measures were introduced was −11.0% (95% confidence interval − 22.0% to 1.5%), resulting in a 24% reduction of the newly diagnosed breast cancer cases in Croatia during April, May, and June compared with the same period of 2019. However, during 2020, only 1% fewer new cases were detected than in 2019, or 6% fewer than what would be expected based on the linear trend during 2017–2019. CONCLUSION: It seems that national health care system measures for controlling the spread of COVID‐19 had a detrimental effect on the number of newly diagnosed breast cancer cases in Croatia during the first lockdown. As it is not plausible to expect an epidemiological change to occur at the same time, this may result in later diagnosis, later initiation of treatment, and less favorable outcomes in the future. However, the effect weakened after the first lockdown and COVID‐19 control measures were relaxed, and it has not reoccurred during the second COVID‐19 wave. Although the COVID‐19 lockdown affected the number of newly diagnosed breast cancers, the oncology health care system has shown resilience and compensated for these effects by the end of 2020. IMPLICATIONS FOR PRACTICE: It is possible to compensate for the adverse effects of COVID‐19 pandemic control measures on breast cancer diagnosis relatively promptly, and it is of crucial importance to do it as soon as possible. Moreover, as shown by this study's results on the number of newly diagnosed breast cancer cases during the second wave of the pandemic, these adverse effects are preventable to a non‐negligible extent. John Wiley & Sons, Inc. 2021-04-28 2021-07 /pmc/articles/PMC8250475/ /pubmed/33856084 http://dx.doi.org/10.1002/onco.13791 Text en © 2021 AlphaMed Press
spellingShingle European Perspectives
Vrdoljak, Eduard
Balja, Melita Perić
Marušić, Zlatko
Avirović, Manuela
Blažičević, Valerija
Tomasović, Čedna
Čerina, Dora
Bajić, Žarko
Miše, Branka Petrić
Lovasić, Ingrid Belac
Flam, Josipa
Tomić, Snježana
COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title_full COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title_fullStr COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title_full_unstemmed COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title_short COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
title_sort covid‐19 pandemic effects on breast cancer diagnosis in croatia: a population‐ and registry‐based study
topic European Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250475/
https://www.ncbi.nlm.nih.gov/pubmed/33856084
http://dx.doi.org/10.1002/onco.13791
work_keys_str_mv AT vrdoljakeduard covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT baljamelitaperic covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT marusiczlatko covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT avirovicmanuela covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT blazicevicvalerija covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT tomasoviccedna covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT cerinadora covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT bajiczarko covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT misebrankapetric covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT lovasicingridbelac covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT flamjosipa covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy
AT tomicsnjezana covid19pandemiceffectsonbreastcancerdiagnosisincroatiaapopulationandregistrybasedstudy